GLPBio

Surfactin

Catalog No.: GC70627Purity:>98.00%
Surfactin, a highly powerful biosurfactant produced by various strains of the genus Bacillus, exhibits antibacterial, antiviral, antitumor, and hemolytic activities.

Die Produkte sind ausschließlich für Forschungszwecke bestimmt. Nicht zur Anwendung am Menschen. Wir verkaufen nicht an Patienten.


Surfactin
Cas No.: 252023-70-4
1 mgIn Stock
$42.00
1
5 mgIn Stock
$93.00
1
10 mgIn Stock
$149.00
1
25 mgIn Stock
$324.00
1
50 mgIn Stock
$554.00
1

Zitate (Citations)

1 publicationsPublikationen von Forschern, die dieses Produkt verwenden

Beschreibung (Description)

Surfactin, a highly powerful biosurfactant produced by various strains of the genus Bacillus, exhibits antibacterial, antiviral, antitumor, and hemolytic activities[1]. Surfactin increases the permeability of Propionibacterium acnes’ cell wall, allowing alkaline phosphatase to leak into the extracellular environment, and prevents Staphylococcus aureus adhesion as well as biofilm formation on surfaces[2]. Surfactin has been widely used in preclinical models to inhibit the growth of various cancer cells and as a component of nanocarriers to improve the efficiency and targeting of drug delivery[3].

In vitro, Surfactin inhibited the growth of MCF-7 cells in a dose- and time-dependent manner, with IC50 values at 24, 48, and 72h of 82.6μM, 27.3μM, and 14.8μM, respectively[4]. Pretreatment with 60µg/ml Surfactin for 1 hour downregulated lipopolysaccharide (LPS)-induced TLR4 protein expression in macrophages and reduced the levels of IFN-γ, IL-6, iNOS, and nitric oxide (NO)[5]. Treatment with 30µM Surfactin for 24 hours induced apoptosis in LoVo cells, accompanied by DNA fragmentation, changes in membrane polarity, and an increase in the cleavage level of caspase-3[6].

In vivo, Surfactin treatment via daily intragastric administration at a dose of 80mg/kg for 6 consecutive weeks alleviated dextran sulfate sodium (DSS)-induced colitis and depression-like behaviors in mice, and mitigated gut microbiota dysbiosis and colonic intestinal barrier dysfunction[7]. Daily oral administration of Surfactin at a dose of 80mg/kg for 12 consecutive weeks improved pancreatic function and glucose metabolism, promoted insulin secretion, and inhibited glucagon release in type 2 diabetic mice[8].

References:
[1] Seydlová G, Svobodová J. Review of surfactin chemical properties and the potential biomedical applications[J]. Central European Journal of Medicine, 2008, 3(2): 123-133.
[2] Chen X, Lu Y, Shan M, et al. A mini-review: mechanism of antimicrobial action and application of surfactin[J]. World Journal of Microbiology and Biotechnology, 2022, 38(8): 143.
[3] Wu Y S, Ngai S C, Goh B H, et al. Anticancer activities of surfactin and potential application of nanotechnology assisted surfactin delivery[J]. Frontiers in pharmacology, 2017, 8: 761.
[4] Cao X, Wang A H, Jiao R Z, et al. Surfactin induces apoptosis and G2/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation[J]. Cell biochemistry and biophysics, 2009, 55(3): 163-171.
[5] Zhang Y, Liu C, Dong B, et al. Anti-inflammatory activity and mechanism of surfactin in lipopolysaccharide-activated macrophages[J]. Inflammation, 2015, 38(2): 756-764.
[6] Kim S, Kim J Y, Kim S H, et al. Surfactin from Bacillus subtilis displays anti‐proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression[J]. FEBS letters, 2007, 581(5): 865-871.
[7] Chen X, Zhao H, Lu Y, et al. Surfactin mitigates dextran sodium sulfate-induced colitis and behavioral disorders in mice by mediating gut–brain-axis balance[J]. Journal of Agricultural and Food Chemistry, 2023, 71(3): 1577-1592.
[8] Chen X, Zhao H, Lu Y, et al. Surfactin mitigates a high-fat diet and streptozotocin-induced type 2 diabetes through improving pancreatic dysfunction and inhibiting inflammatory response[J]. International journal of molecular sciences, 2022, 23(19): 11086.

Protokoll (Protocol)

Cell experiment [1]:

Cell lines

MCF-7 cells

Preparation Method

MCF-7 cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum, 100U/ml penicillin, 100U/ml streptomycin, and 1% glutamine in a humidified cell incubator with an atmosphere of 5% CO2 at 37°C. 1×105 cells/well were plated in 96-well culture plates. After overnight incubation, the cells were treated with varying concentrations of Surfactin (0, 10, 20, 40, 60, 80, 100μM) for 48h, and cell viability was measured.

Reaction Conditions

0, 10, 20, 40, 60, 80, 100μM; 48h

Applications

Surfactin treatment reduced the cell viability of MCF-7 cells in a dose-dependent manner.
Animal experiment [2]:

Animal models

Male Kunming mice

Preparation Method

Male Kunming mice (4 weeks old) were housed under constant conditions (temperature 25°C; 12h light-dark cycle) in an aseptic environment and fed a basic diet and water for 7 days to allow acclimatization. All mice were fed and drank ad libitum. After being weighed, the mice were randomly divided into 3 groups (n=8 per group): Control, mice treated with orally administered 0.9% saline and treated with distilled water; Model, mice treated with orally administered saline and induced with 2% DSS solution; Surfactin, mice treated with orally administered 80mg/kg/day Surfactin and induced with 2% DSS. The colonic tissues in mice were collected 6 weeks later for analysis.

Dosage form

80mg/kg/day; 6 weeks; p.o.

Applications

Surfactin treatment mitigated DSS-induced colitis and intestinal barrier dysfunction in mice.

References:
[1] Cao X, Wang A H, Jiao R Z, et al. Surfactin induces apoptosis and G2/M arrest in human breast cancer MCF-7 cells through cell cycle factor regulation[J]. Cell biochemistry and biophysics, 2009, 55(3): 163-171.
[2] Chen X, Zhao H, Lu Y, et al. Surfactin mitigates dextran sodium sulfate-induced colitis and behavioral disorders in mice by mediating gut–brain-axis balance[J]. Journal of Agricultural and Food Chemistry, 2023, 71(3): 1577-1592.

Produktdokumente (Product Documents)

Purity:>98.00%Appearance:A solid

Chemische Eigenschaften (Chemical Properties)

CAS-Nr.
252023-70-4
Molekulargewicht
1025.04(Average)
Löslichkeit
DMSO : 50 mg/mL (Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO); H2O : 31.25 mg/mL (Need ultrasonic)
Lagerung
Store at -20°C
Allgemeine Hinweise
Wählen Sie anhand der Löslichkeitsdaten des Produkts ein geeignetes Lösungsmittel. Aliquotieren Sie die Stammlösung nach der Herstellung, um wiederholte Gefrier-Auftau-Zyklen zu vermeiden.
Verwenden Sie Stammlösungen bei Lagerung bei -80°C innerhalb von 6 Monaten bzw. bei -20°C innerhalb von 1 Monat.
Zur Verbesserung der Löslichkeit das Röhrchen auf 37°C erwärmen und für eine angemessene Dauer beschallen.
Versandbedingungen
Evaluierungsmuster werden mit Kühlakkus versandt. Andere verfügbare Größen werden bei Raumtemperatur oder auf Anfrage mit Kühlakkus versandt.

Rechner (Calculators)Molarität / Verdünnung / Molekulargewicht / Einheitenumrechnung / In-vivo-Formulierung / Löslichkeit

g/mol

Reviews

Review for Surfactin

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%